Adicet is a biotechnology company focused on developing first-in-class off-the-shelf allogeneic gamma-delta T cell therapies for cancer and autoimmune diseases. Their innovative approach aims to provide accessible, transformative treatments by using donor-derived cells to target and kill cancer cells and reset the immune system for patients with autoimmune conditions.